OCT4A is best known as a "master" transcription factor involved in stem cell pluripotency and self renewal in concert with SOX2 and NANOG. Although there has been some indication of a dialog between OCT4 and elements of DNA repair, 1 it is involved in activating cell cycle checkpoints, DNA repair, activating the "accelerated" senescence response to DNA damage, blocking apoptosis, and regulating the WIP1 phosphatase. 6 These observations indicate that OCT4A is an important regulator in the p53/DDR pathway that especially controls the p21 Cip1 protein and its various effects on the cell; however, it clearly exerts additional p21 Cip1 -independent activities, such as in establishing the G2/M-arrested pre-senescent transition state itself.
The results further suggest that OCT4A functions in tandem with AMPK in directing cell-fate decisions in this cancer model, notably the evolution of the senescence phenotype; this complex process in part involves the AMPK/autophagy-driven cytoplasmic sequestration of p16
Ink4a , which is a mediator of the transition from pre-to terminal senescence, redirecting some cells toward mitotic recovery. These events represent a compelling target for therapeutic intervention by overcoming the resistance of cancer stem cells to DNA-damaging anticancer agents. Indeed, Huna et al. 2 note that in some scenarios the application of drugs that modulate AMPK/autophagy might serve to redirect chemotherapy-refractory tumor cells into an apoptotic death pathway. This strategy is [C]) has characteristics of both self renewal and senescence. OCT4A suppresses p21
Cip1 and senescence while enhancing mitotic recovery. Note the reported roles of p53 in both promoting and blocking senescence 4 and of AMPK in activating the p53 axis in response to DNA damage. certainly worth testing. The findings also inform treatment strategies that target the therapy-induced senescence phenotype in cancer cells which has a complex, often negative, relationship to therapeutic outcome. The outstanding contribution of this research team that demonstrates a pivotal role for OCT4A and autophagy in cellautonomous DDR-related cell fate decisions will hopefully encourage meaningful discussion and further unraveling of the complex signaling dynamics and relationships between self renewal, senescence and cell cycle checkpoints/DDR in cancer cells. Such insight into the responses triggered by therapeutic agents in different cancer cell types will be crucial for designing effective approaches for preventing and treating this devastating disease.
